Vyvanse and Mupirocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Mupirocin (mupirocin). Common drug interactions include facial pain among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Mupirocin. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.



On Jul, 04, 2026

40 people who take Vyvanse and Mupirocin together, and have interactions are studied.

Vyvanse and Mupirocin drug interactions.

What are the common drug interactions of Vyvanse and Mupirocin, by gender? *:

female:

  1. Facial pain
  2. Foreign body sensation in eyes (feeling of something in eye)
  3. Oral discomfort (pain or irritation in mouth)
  4. Oral pain
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Swelling face
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Acne cystic (skin problems that cause pimples)
  9. Back pain
  10. Blood alcohol increased

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Skeletal injury (bone and supporting muscle injury)
  6. Wrist fracture
  7. Acne (skin problems that cause pimples)
  8. Alopecia (absence of hair from areas of the body)
  9. Bone density decreased
  10. Bone loss

What are the common drug interactions of Vyvanse and Mupirocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Arthralgia (joint pain)
  2. Dry eye (lack of adequate tears)
  3. Eye colour change
  4. Eye irritation
  5. Eye pruritus (eye itching)
  6. Oral mucosal blistering (mouth ulcer)

10-19:

  1. Fatigue (feeling of tiredness)
  2. Sinusitis (inflammation of sinus)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Respiratory tract infection
  6. Upper respiratory tract infection
  7. Viral infection
  8. White blood cell count increased
  9. Diarrhoea
  10. Fall

20-29:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Loss of consciousness
  4. Sleep inertia (feeling of grogginess and disorientation that can come with awakening from a deep sleep)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Acne (skin problems that cause pimples)
  7. Joint swelling
  8. Acne cystic (skin problems that cause pimples)
  9. Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
  10. Drug hypersensitivity

30-39:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Infusion related reaction
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Sinusitis (inflammation of sinus)
  5. Weight fluctuation
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Influenza
  8. Viral infection
  9. Blood urine present
  10. Gastrointestinal infection (infection of stomach and intestine)

40-49:

n/a

50-59:

  1. Infection
  2. Middle ear effusion (fluid in middle ear)
  3. Pyrexia (fever)
  4. Road traffic accident
  5. Sinus disorder (disease of sinus)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  8. Upper respiratory tract infection
  9. Cellulitis (infection under the skin)
  10. Chronic kidney disease

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Blood calcium increased
  3. Swelling face
  4. Therapeutic response unexpected
  5. Urinary tract infection
  6. Vitamin d increased
  7. Chronic kidney disease
  8. Death
  9. Decreased appetite
  10. Dry mouth

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 16 people, 40.00%
  2. Pain: 5 people, 12.50%
  3. Infection: 4 people, 10.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.00%
  5. Oedema (fluid collection in tissue): 3 people, 7.50%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.50%
  7. Hiv Infection: 3 people, 7.50%
  8. High Blood Pressure: 3 people, 7.50%
  9. Drowsiness: 3 people, 7.50%
  10. Immune System Disorder: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and Mupirocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vyvanse and Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyvanse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and mupirocin (the active ingredients of Vyvanse and Mupirocin, respectively), and Vyvanse and Mupirocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: